XEPLION, also known by its generic name paliperidone palmitate, is a long-acting injectable antipsychotic medication primarily used in the treatment of schizophrenia. It belongs to the class of drugs known as atypical antipsychotics, which work by helping to restore the balance of certain natural substances in the brain, such as neurotransmitters dopamine and serotonin. XEPLION is designed for intramuscular injection, typically administered once a month, making it a convenient option for patients seeking a sustained-release form of medication to manage their symptoms. Its extended-release formula is intended to provide stable medication levels in the body, aiming to improve adherence to treatment and reduce the likelihood of relapse. Like all medications, XEPLION can have side effects, and its use should be closely monitored by a healthcare professional.